eartocl的部落格

New methods of remedy are appear to scrap macular process which is one of the prevailing causes of terrible figment of the imagination loss in adults in the US and the industrialized global.

The new drugs involve Macugenability from Pfizer/Eyetech, Retaaneability from Alcon, Corticosteroid and Lucentisability. Macugenability (Pegaptanib Metal) is a new fresh tablets thatability targets the body?s deadly signals thatability result in unusual bodily fluid vessels to develop. This medication industrial plant by targetingability the protein active in the maturation of out of the ordinary humor vessels. A gp injectsability this pills into the bodily fluid water in the eye after desensitizing it. Macugenability boodle the making of new humour vessels and decreases escape from surviving humor vessels. This care is recurrent both six weeks helps to obviate added loss of imaging.

Retaane (Anecortave Ethanoate) is a man-made organic compound thatability targets ruinous processes thatability raison d'être irregular bodily fluid vessels to spring in the eye and also blocks sixfold deadly signals.

Kenalog (Triamcinolone) is a steroid utilized to treat eye redness and distension. Investigation is going on to discover whether injectionsability of this linctus may well too restore illusion for relatives smitten by macular degeneration.

Another potential agent is Lucentisability (Ranibizumab). Lucentisability also plant by clogging growing of deviant humor vessels in the eye. This tablets shows give an undertaking in not individual preventingability more illusion loss but besides in reversingability the personal property of macular devolution. This remedy is before long in medical institution trials and is anticipated to be going spare for prescription single by the freshman common fraction of 2007.

According to Age-Relatedability Eye Bug Become skilled at (AREDS), a each day addendum of 500 milligramsability (mg) of nutrition C, 400 supranational units (IU) of victuals E, 15 mg of of import provitamin a (often as nutrition A ? up to 25,000 IU), 80 mg of zinc (as zn compound), and 2 mg of atomic number 29 (as cuprous oxide) can trim the peril of advancing to small to grave imagery loss by up to 25 pct. For group with intermediate to precocious macular degeneration, this den indicatesability thatability bodily process of in flood doses of zinc, beta carotene, and vitaminsability C and E is efficient in reduction the danger of added nightmare loss.

Research into new way of treating macular process is an in progress procedure and new advances hang on to acquiring according. It is advisable to inquire a doc sporadically to know whether new treatmentsability have been introducedability.